InvestorsHub Logo
Followers 16
Posts 329
Boards Moderated 0
Alias Born 01/21/2016

Re: None

Monday, 10/10/2016 3:45:19 PM

Monday, October 10, 2016 3:45:19 PM

Post# of 402273
I also think that the premise of ag-antag abuse deterrence, will become multi-modal, and become the mainstay for any drug that can be abused.

Think about it, "Pfizer/Purdue/etc. caring for the addicted by forgoing any medication, that has potential for abuse, that is not in fact inherently abuse deterrent". That is a play I see big pharma capitalizing on for sure. All the while their money, their real motive, is stacking up in the background. Hidden by the guise of suppose "care-for-the-population" movement, from the "new" brand name drugs, tailored to current US addiction problems Big Pharma will grow.

We will be apart of that growth, either directly, through independent marketing and sales, or the more likely, indirectly, through an acquirer intending to use our pipeline and technology.


Just you wait and see. ELTP is good to go. The FDA is just walling off/barring approvals for IR Abuse Deterrents, until they have enough comparator data and viable market place competitors.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News